Skip to content

Insider · CIK 0001960418

Joshua Aiello

officer

Files at OBIO (Orchestra BioMed Holdings, Inc.). First filing -, latest -.

Joshua Aiello files SEC Form 4 as officer at OBIO (Orchestra BioMed Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Joshua Aiello has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 9 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 26, 2026OBIO
Orchestra BioMed Holdings, Inc.
FTax withholding
Common Stock, par value $0.0001 per share
-203$5.26$1,06818,441Aug 28, 2026
Mar 25, 2026OBIO
Orchestra BioMed Holdings, Inc.
FTax withholding
Common Stock, par value $0.0001 per share ("Common Stock")
-241$4.57$1,10118,644Mar 27, 2026
Feb 12, 2026OBIO
Orchestra BioMed Holdings, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+70,000$0.00$070,000Feb 13, 2026
Jan 2, 2026OBIO
Orchestra BioMed Holdings, Inc.
FTax withholding
Common Stock, par value $0.0001 per share ("Common Stock")
-241$4.31$1,03918,885Jan 2, 2026
Sep 17, 2025OBIO
Orchestra BioMed Holdings, Inc.
FTax withholding
Common Stock, par value $0.0001 per share ("Common Stock")
-203$2.46$49919,126Sep 19, 2025
Aug 7, 2025OBIO
Orchestra BioMed Holdings, Inc.
AGrant or award
Common Stock, par value $0.0001 per share ("Common Stock")
+15,000$0.00$019,329Aug 8, 2025
Jun 18, 2025OBIO
Orchestra BioMed Holdings, Inc.
FTax withholding
Common Stock, par value $0.0001 per share ("Common Stock")
-393$2.99$1,1754,329Jun 20, 2025
Apr 4, 2025OBIO
Orchestra BioMed Holdings, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+48,000$0.00$048,000Apr 4, 2025
Mar 26, 2025OBIO
Orchestra BioMed Holdings, Inc.
FTax withholding
Common Stock, par value $0.0001 per share
-278$4.38$1,2184,722Mar 28, 2025

Questions about Joshua Aiello

Answered from the filings on this page, as of the latest one.

Is Joshua Aiello buying or selling?

Joshua Aiello has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Joshua Aiello's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joshua Aiello has 0.

Where does Joshua Aiello file Form 4?

Joshua Aiello has filed Form 4 at OBIO (Orchestra BioMed Holdings, Inc.) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Joshua Aiello: insider trades and track record | InsiderTell